Last week, Congress officially passed the ADVANCE Act after the bill successfully navigated its way through the Senate.
I’ll admit it was a rare thing to witness watching both sides of the aisle come together, especially during a heated election year.
And I’m not talking about some pass-by-the-skin-of-your-teeth type of passage, either. The ADVANCE Act flew threw the Senate by a vote of 88 to 2; the bill enjoyed wide bipartisan in the House as well after it was passed 393 to 13.
Forgotten was the bickering and vitriolic division between the two parties that have a bad habit of only passing pork-laden legislation. For once, our politicians may have gotten things right.
“So why should I care about this?” you ask.
Well, that’s easy. Of all the virtue signaling promises of a greener future, the U.S. is finally pushing forward with a a true “all-of-the-above” energy strategy that will develop next-gen nuclear technology.
And it’s about time, too.
Our analysts have traveled the world over, dedicated to finding the best and most profitable investments in the global energy markets. All you have to do to join our Energy and Capital investment community is sign up for the daily newsletter below.The Best Free Investment You’ll Ever Make
The ADVANCE Act: What You Should Know
Let’s take a second and actually look at what this bill accomplishes, shall we?
The Accelerating Deployment of Versatile, Advanced Nuclear for Clean Energy Act — or ADVANCE Act, for short (people do love their acronyms, don’t they) — does several things. For those of you interested, you can actually read the full text here.
Here’s a quick summary:
“This bill sets forth provisions to develop and deploy advanced nuclear fuel for the United States and certain allied countries, restrict the possession or ownership of enriched uranium from Russia or China, clean up hazardous land, and establish related requirements.
Specifically, the bill provides incentives for developing and deploying new nuclear technologies, such as reduced licensing fees and prize awards for deploying such technologies. It also extends through 2045 the indemnification policy under the Price-Anderson Act that limits liability related to the nuclear industry.
It also requires the Nuclear Regulatory Commission (NRC) to (1) develop a process that enables timely licensing of nuclear production facilities or utilization facilities at brownfield sites, and (2) establish an initiative to enhance preparedness and coordination with respect to the qualification and licensing of advanced nuclear fuel. NRC may hire specialized staff without regard to civil service laws to address its critical licensing or regulatory oversight needs.
The NRC must also coordinate certain international nuclear activities and may establish an International Nuclear Reactor Export and Innovation Branch within the Office of International Programs. The bill allows certain foreign entities to receive licenses under the Atomic Energy Act of 1954 for nuclear utilization facilities as specified by the bill.
The bill also allows the Environmental Protection Agency to conduct activities to assist in cleaning up certain abandoned mining sites on tribal lands that are hazardous.”
Essentially, it facilitates the development and deployment of next generation nuclear energy technology.
However, there’s something in the ADVANCE Act that is particularly special for our investment community here at Energy & Capital.
Did you catch it?
I’ll give you a hint… it’s been something we’ve been waiting a long time for, and Congress just opened a huge window of opportunity for any investor smart enough to take the time to see it.
Turning the ADVANCE Act Into Pure Profit
Last week, I told you that the real money won’t be in building the multi-billion dollar next-gen nuclear plants, which are notorious for delays and running over budget.
Truth is, the real money will be in FUELING them.
And one thing that the ADVANCE Act does is expedite the NRC licensing process for advanced nuclear fuel technologies, as well as enable the testing and demonstration of accident tolerant fuels for existing commercial nuclear reactors.
We’re talking about more than just traditional reactors.
Look, it wasn’t a coincidence that the day before the ADVANCE Act was passed in the Senate, the Department of Energy announced it would spend $900 million supporting the initial U.S. deployment of Generation III+ small modular reactors.
Although it received little attention in media headlines, the ADVANCE Act was a landmark piece of legislation for the U.S. nuclear industry. This also has put us on a path of developing the kind of reliable baseload power that our grid is craving right now.
That’s why I strongly recommend you take just a minute out of your day and see just who’s in position to fuel tomorrow’s advanced nuclear power.
You can find all the details in my latest investment presentation right here.
Until next time, Keith Kohl A true insider in the technology and energy
markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new
technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the
Managing Editor of Energy & Capital, as well as the
investment director of Angel Publishing’s
Energy Investor and Technology and
Opportunity. For nearly two decades, Keith has been providing in-depth coverage of the hottest
investment trends before
they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution
currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on
key advancements in robotics and AI technology. Keith’s keen trading acumen and investment research also extend all the way into
the complex biotech sector,
where he and his readers take advantage of the newest and most groundbreaking medical therapies being
developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s
to lab scientists grinding out the latest medical technology and treatments. You can join his vast
investment community and target the most profitable biotech stocks in Keith’s Topline Trader advisory newsletter.